<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04376229</url>
  </required_header>
  <id_info>
    <org_study_id>J2008</org_study_id>
    <secondary_id>IRB00228501</secondary_id>
    <nct_id>NCT04376229</nct_id>
  </id_info>
  <brief_title>Proton Radiation Therapy Registry</brief_title>
  <official_title>Proton Radiation Therapy Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Johns Hopkins Proton Therapy center is establishing a registry to capture the full 3D
      radiation dosimetry delivered to the patient, baseline clinical data, and disease, toxicity
      and quality of life outcomes. The goal is to have all patients treated at the proton center
      to be included in the registry to enable future comparisons of treatment outcomes to assist
      in understanding which patients can benefit from the use of protons.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Proton based radiation therapy has considerable dosimetric advantages over the standard
      photon based radiation therapy, with a significantly higher cost. The clinical advantages,
      however, may not be realized for all patient populations, even with the improved dose
      distributions. Establishing the clinical efficacy of proton therapy requires years of
      experience treating patients. The goal is to accelerate the knowledge gain through the use of
      the registry that allows for detailed information to be captured and is inclusive of every
      patient treated.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2020</start_date>
  <completion_date type="Anticipated">June 2035</completion_date>
  <primary_completion_date type="Anticipated">June 2035</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>15 Years</target_duration>
  <primary_outcome>
    <measure>Research registry of cancer patients receiving proton radiation therapy</measure>
    <time_frame>15 years</time_frame>
    <description>This is a clinic based registry of cancer patients' data from participants to be collected over 15 years. The registry will be populated with 3D anatomy and radiation dosimetry from the RayStation treatment planning system used to plan all proton therapy patients. Clinical data will be extracted electronically from the MOSAIQ oncology information system used to manage the radiation therapy treatments. Structured clinical assessments will be routinely captured in the clinical workflow during patient encounters. Patient reported outcomes will be captured with iPad's using the OncoBrowser tools developed in radiotherapy that also interface with MOSAIQ.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Cancer, Therapy-Related</condition>
  <arm_group>
    <arm_group_label>Cancer patients receiving proton radiation therapy</arm_group_label>
    <description>Registry of cancer patients who receive proton radiation therapy to track disease and toxicity outcomes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Registry</intervention_name>
    <description>Registry of cancer patients who receive proton radiation therapy</description>
    <arm_group_label>Cancer patients receiving proton radiation therapy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        cancer patients with proton therapy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients treated at the proton center.

        Exclusion Criteria:

          -  Any other than what is supplied in the inclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Akila Viswanathan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Akila Viswanathan, MD</last_name>
    <phone>410-502-1421</phone>
    <email>anv@jhmi.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dana Kaplin, MPH</last_name>
    <phone>410-614-3950</phone>
    <email>dkaplin1@jhmi.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sibley Memorial Hospital</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20016</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Akila Viswanathan, MD</last_name>
      <phone>410-502-1421</phone>
      <email>anv@jhmi.edu</email>
    </contact>
    <contact_backup>
      <last_name>Dana Kaplin, MPH</last_name>
      <phone>41--614-3950</phone>
      <email>dkaplin1@jhmi.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Suburban Hospital</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20814</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Akila Viswanathan, MD</last_name>
      <phone>410-502-1421</phone>
      <email>anv@jhmi.edu</email>
    </contact>
    <contact_backup>
      <last_name>Dana Kaplin, MPH</last_name>
      <phone>410-614-3950</phone>
      <email>dkaplin1@jhmi.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Bayview Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21224</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Dana Kaplin, MPH</last_name>
      <phone>410-614-3950</phone>
      <email>dkaplin1@jhmi.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Akila Viswanathan, MD</last_name>
      <phone>410-502-1421</phone>
      <email>anv@jhmi.edu</email>
    </contact>
    <contact_backup>
      <last_name>Dana Kaplin, MPH</last_name>
      <phone>410-614-3950</phone>
      <email>dkaplin1@jhmi.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Todd McNutt, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zhi Cheng, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 30, 2020</study_first_submitted>
  <study_first_submitted_qc>May 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 6, 2020</study_first_posted>
  <last_update_submitted>May 1, 2020</last_update_submitted>
  <last_update_submitted_qc>May 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>proton therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms, Second Primary</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

